Null on patient outcome (RCT)
A GPT-4o assistant built into the medical record improved Kenyan clinicians' notes and plans but did not reduce treatment failure for 9,691 patients.
A pragmatic cluster-randomized trial in 16 Penda Health clinics in Nairobi (Nature Medicine, June 2026) gave 52 of 103 clinical officers the AI Consult tool; treatment failure within 14 days was 2.2% with it vs 2.0% without (adjusted OR 0.77, p=0.13), while blinded reviewers rated diagnoses, notes, and treatment plans better in the AI arm.
Sources
- primaryNature Medicine: Generative AI-enabled clinical decision support system in primary care — a pragmatic, cluster-randomized trial (open access, PMC)pmc.ncbi.nlm.nih.gov
- primaryLSHTM Research Online record (abstract and CC BY PDF)researchonline.lshtm.ac.uk
- secondaryUniversity of Birmingham news releasebirmingham.ac.uk
Editor's notes
Pairs with the earlier Penda/OpenAI quality-improvement study of an almost identical tool (Korom et al., preprint), which reported fewer clinician errors without patient-outcome randomization. Clinicians fully followed only 19.5% of 1,000 reviewed red alerts. Protocol violations: 45 control-arm encounters had tool access through an EMR configuration error.
Related
History
- The editor has not yet read the Nature Medicine paper; published unreviewed.
- Added by weekly research run; verified against the open-access full text.
Cite this entry
“A GPT-4o assistant built into the medical record improved Kenyan clinicians' notes and plans but did not reduce treatment failure for 9,691 patients.” Because of AI, updated Oct 22, 2026. https://becauseofai.org/entry/kenya-ai-consult-null@misc{becauseofai_kenya_ai_consult_null,
title = {A GPT-4o assistant built into the medical record improved Kenyan clinicians' notes and plans but did not reduce treatment failure for 9,691 patients.},
howpublished = {\url{https://becauseofai.org/entry/kenya-ai-consult-null}},
note = {Because of AI registry, updated Oct 22, 2026},
year = {2026}
}